Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL ACTINIC KERATOSIS TREATMENT INDUSTRY 2.1 Summary about Actinic Keratosis Treatment Industry 2.2 Actinic Keratosis Treatment Market Trends 2.2.1 Actinic Keratosis Treatment Production & Consumption Trends 2.2.2 Actinic Keratosis Treatment Demand Structure Trends 2.3 Actinic Keratosis Treatment Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 Destructive Treatment 4.2.2 Photodynamic Therapy 4.2.3 Topical Medications 4.2.4 Others 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Hospital 4.3.2 Clinic 4.3.3 Others 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 Destructive Treatment 5.2.2 Photodynamic Therapy 5.2.3 Topical Medications 5.2.4 Others 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Hospital 5.3.2 Clinic 5.3.3 Others 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 Destructive Treatment 6.2.2 Photodynamic Therapy 6.2.3 Topical Medications 6.2.4 Others 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Hospital 6.3.2 Clinic 6.3.3 Others 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 Destructive Treatment 7.2.2 Photodynamic Therapy 7.2.3 Topical Medications 7.2.4 Others 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Hospital 7.3.2 Clinic 7.3.3 Others 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 Destructive Treatment 8.2.2 Photodynamic Therapy 8.2.3 Topical Medications 8.2.4 Others 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Hospital 8.3.2 Clinic 8.3.3 Others 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 Destructive Treatment 9.2.2 Photodynamic Therapy 9.2.3 Topical Medications 9.2.4 Others 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Hospital 9.3.2 Clinic 9.3.3 Others 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 DUSA Pharmaceuticals 10.1.2 Novartis 10.1.3 Perrigo 10.1.4 LEO Pharma 10.1.5 Bausch Health 10.1.6 Taro Pharmaceutical 10.1.7 Galderma (Nestle) 10.1.8 Biofrontera 10.1.9 Almirall 10.1.10 Tolmar Pharmaceutical 10.2 Actinic Keratosis Treatment Sales Date of Major Players (2017-2020e) 10.2.1 DUSA Pharmaceuticals 10.2.2 Novartis 10.2.3 Perrigo 10.2.4 LEO Pharma 10.2.5 Bausch Health 10.2.6 Taro Pharmaceutical 10.2.7 Galderma (Nestle) 10.2.8 Biofrontera 10.2.9 Almirall 10.2.10 Tolmar Pharmaceutical 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

List of Table 1.Table Actinic Keratosis Treatment Product Type Overview 2.Table Actinic Keratosis Treatment Product Type Market Share List 3.Table Actinic Keratosis Treatment Product Type of Major Players 4.Table Brief Introduction of DUSA Pharmaceuticals 5.Table Brief Introduction of Novartis 6.Table Brief Introduction of Perrigo 7.Table Brief Introduction of LEO Pharma 8.Table Brief Introduction of Bausch Health 9.Table Brief Introduction of Taro Pharmaceutical 10.Table Brief Introduction of Galderma (Nestle) 11.Table Brief Introduction of Biofrontera 12.Table Brief Introduction of Almirall 13.Table Brief Introduction of Tolmar Pharmaceutical 14.Table Products & Services of DUSA Pharmaceuticals 15.Table Products & Services of Novartis 16.Table Products & Services of Perrigo 17.Table Products & Services of LEO Pharma 18.Table Products & Services of Bausch Health 19.Table Products & Services of Taro Pharmaceutical 20.Table Products & Services of Galderma (Nestle) 21.Table Products & Services of Biofrontera 22.Table Products & Services of Almirall 23.Table Products & Services of Tolmar Pharmaceutical 24.Table Market Distribution of Major Players 25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 27.Table Global Actinic Keratosis Treatment Market Forecast (Million USD) by Region 2021f-2026f 28.Table Global Actinic Keratosis Treatment Market Forecast (Million USD) Share by Region 2021f-2026f 29.Table Global Actinic Keratosis Treatment Market Forecast (Million USD) by Demand 2021f-2026f 30.Table Global Actinic Keratosis Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f